Arjuna awardee Gaurav, another driver booked in connection with accident that claimed three lives
Barmer: Arjuna awardee Gaurav Gill and another driver were booked on Sunday in connection with an accident during a National Rally Championship race here in which a couple and their young son were killed, police said.
A police official said companies involved in the event -- Maxperienace, Mahindra, JK Tyres, MRF Tyres and the Federation of Motor Sports Club of India -- have also been named in the FIR.
Additional Superintendent of Police Khinv Singh said the FIR was lodged at Samdari police station at 2 am on Sunday on a complaint by the deceased's elder son Rahul.
Rahul claimed that his parents were standing along the road with the motorcycle, talking to his younger brother, when Gill's car hit them and two other cars coming from behind also crushed them.
Gill and driver M Sharif were booked under Section 304 of the Indian Penal Code (culpable homicide not amounting to murder), the ASP said, adding that their names were written on the vehicle that hit the motorcycle of the deceased.
Meanwhile, the bodies of Narendra Kumar, his wife Pushpa Devi and son Jitendra were still lying at the spot as villagers and family members demanded compensation, government job to a kin and the arrest of the accused.
"The stalemate is continuing. Efforts are being made to end it but the organisers of the rally are not cooperating. The villages are demanding since yesterday that the organisers come to the spot but they are not responding," SHO of Samdari Police Station Bhuta Ram said.
He said that there the local police had no update about the whereabouts of Gaurav Gill.
The National Rally Championship was being held in Barmer when the motorcycle was hit by Gill's car that left the couple and their son dead.
Rahul alleged that there were no proper safety and security arrangements in place during the race, but Barmer Superintendent of Police Shivraj Meena said that adequate measures were adopted for the rally.
Internal roads of various villages in Barmer were used as the track for the rally.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
Jamia prof receives Rs 94 lakh grant to formulate AI-driven drug to treat breast cancer
New Delhi (PTI): An associate professor at Jamia Millia Islamia has been awarded a research grant of approximately Rs 94 lakh by the prestigious ICMR to support research in leveraging Artificial Intelligence for treatment of breast cancer.
The Indian Council of Medical Research (ICMR) has granted funding to Raza to develop cutting-edge tools for AI-guided drug design, focusing on optimising drug compounds, identifying therapeutic targets, and formulating novel treatment strategies for breast cancer, a statement by the varsity said on Friday.
One such promising drug compound 'DdpMPyPEPhU' already patented by Raza will be further explored under this initiative, the statement said.
This research will address critical challenges in breast cancer treatment and is expected to yield transformative outcomes that could impact healthcare practices globally, it added.
The three-year funding will facilitate advanced experimentation, foster collaboration with leading experts, and accelerate the development of innovative solutions for breast cancer treatment.
Jamia Vice-Chancellor Mazhar Asif and Registrar Md. Mahtab Alam Rizvi congratulated Raza on this accomplishment.
Asif stated, “This is a moment of immense pride for JMI. Raza’s recognition by ICMR underscores the university’s commitment to fostering research excellence and innovation. His groundbreaking work showcases JMI’s vital contributions to integrating AI in healthcare research.”
Expressing gratitude for the recognition, Raza said, “I am deeply honoured to receive this grant from ICMR. It represents a tremendous opportunity to advance our research on AI- driven drug design and contribute to better health outcomes for millions. I am thankful to my research team, collaborators and ICMR for their unwavering support.”
Raza is known for his research in the application of AI in healthcare, focusing on designing and optimising drug compounds through AI-based multitarget docking, molecular simulations, and genomics-driven personalised medicine.
